Deals 20 May 2014 Orthocell considers IPO push Bookmark Save articles for future reference. Subscribe to BN Log In Share to Facebook X LinkedIn Biotech player Orthocell has appointed two financial advisory firms to seek out investors as part of the company's plans to go public.
Deals 16 Oct 2013 NZ biotech chooses Australia for IPO Bookmark Save articles for future reference. Subscribe to BN Log In Share to Facebook X LinkedIn Perth based stockbroking firm Patersons Securities is punting on investors' emerging appetite for biotech stocks, agreeing to underwrite New Zealand biopharmaceutical company Innate Immunotherapeutics's $16.5 million initial public offering.
